<DOC>
	<DOCNO>NCT01021696</DOCNO>
	<brief_summary>In nurse home ( NHs ) 80 % patient dementia , 60 % -80 % exhibit behavioural disturbance ( BPSD ) , 60 % pain . Both pain BPSD common severe dementia . Since old person dementia less communicative skill , suffer pain exhibit agitation , pain may contribute factor patient . More 40 % patient BPSD treat neuroleptic despite described side-effects . There urgent need investigate impact individual pain management BPSD patient dementia . It hypothesize - pain increase BPSD patient dementia - individual pain treatment decrease BPSD patient dementia</brief_summary>
	<brief_title>Pain Patients With Dementia Behavioural Disturbances</brief_title>
	<detailed_description>We intend conduct eight week , multi-centre , rater-blinded , cluster randomize , parallel-group trial , follow four week . We choose cluster randomize practical reason . 920 NH patient screen 352 patient moderate severe dementia BPSD include . The treatment period 8 week , follow four week . The primary outcome measure reduction aggression agitation well item measure mean CMAI ( Cohen Mansfield Agitation Inventory ) . Secondary outcome reduction NPI-NH-subscale agitation/aggression item measure Neuropsychiatric Inventory , Nursing Home Version ( NPI-NH ) . Further , want evaluate concomitant use acute medication . Additionally , Activities Daily Living function ( ADL ) MIni Mental State Examination ( MMSE ) use secondary outcome measure . Pain patient dementia assess follow MOBID-2 Pain Scale ( secondary outcome measure ) . MOBID-2 Pain Scale staff-administered behavioural instrument assessment pain old person dementia god validity reliability ( Husebo 2008 , 2009 ) . MOBID-2 base patient 's pain behaviour connection standardise , guide movement different body part , pain behaviour relate internal organ , head skin . Additionally , pain register pain diagnosis , -etiology , -duration . The MOBID-2 score derive caregiver clinical bedside situation morning care . Adverse event record evaluate throughout study primary assessment safety tolerability . Inclusion criterion : Patients either gender , 60 year age old , live nursing home ( NH ) diagnose moderate severe dementia measure Functional Assessment Staging ( FAST ) MMSE , BPSD form agitation / aggression measure subscale NPI-NH CMAI . Exclusion criterion : Patients without cognitive impairment without BPSD . Patients hepatic renal failure disease make impossible follow study schedule .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Aged 65 old Residing NHs least 4 week Dementia accord Diagnostic Statistical Manual Mental Disorders ( DSMIV ) ( American Psychiatric Association 1994 ) , FAST score &gt; 4 ( Hughes 1982 ) . Clinically relevant BPSD , operationally define CMAI score ≥ 39 high or/and least one week history agitation aggression ( Koss 1997 ) . Written , informed consent provide participant ( capacity ) assent ( capacity ) write proxy inform consent legally authorize representative empower make healthrelated decision potential study participant . Clinician responsible care , study clinician considers patient suffers physical condition , would make participation trial distress likely increase suffer Advanced severe medical disease/disorder expect survival le 6 month could interfere participation Psychosis severe mental disorder prior dementia diagnosis ; Severe aggression ( ≥8 ) item 3 NPI subscale , aggression predominant symptom Schizophrenia , schizoaffective disorder bipolar disorder Uncontrolled epilepsy Severe liver impairment Renal failure , measure equivalent estimate creatinine clearance &lt; 50mL/min/1.73m , Severe injury anaemia ( Hb &lt; 8.5 mmol/l ) , comatose state , current enrolment another experimental protocol . Known allergy adverse reaction Paracetamol , Morphine ret , Buprenorphine plaster pregabalin</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Dementia</keyword>
	<keyword>Nursing home</keyword>
	<keyword>Pain treatment</keyword>
	<keyword>Pain assessment</keyword>
	<keyword>Agitation</keyword>
</DOC>